 |
|
|
| Home > Professionals |
 |
| |
 |
| |
| TRT is applying technical and
working knowledge of our rich source of stem cells
and synthetic scaffold material to advance
clinical treatments within the medical community.
These technologies are commercialized through
established corporations and technology licensing
agreements. |
| |
| Read
More... |
| |
|
| |
 |
| |
| The HUCPVC stem cells represent a
platform technology. These cells are equivalent
to bone marrow mesenchymal stromal
cells. |
| |
| Read
More... | |
|
 |
|
 |
| |
| By working with clinicians, TRT
continues to develop innovative methods to use
stem cells as drugs for the benefit of
patients. |
| |
| Read
More... | | |
| |
| | |
|
 |
| Development of HUCPVC Therapy™.
Non-embryonic stem cells for patient care. |
 |
 |
| HUCPVC Storage™ for the long-term
storage of Umbilical Cord Tissue stem cells
collected at the birth of your baby. |
|
 |
| Assisting the natural renewal and
remodeling of bone with OsteoScaf™, our
macroporous biodegradable scaffold. |
| |
|
 |
|
|
| "It's a new
type of Biological Life
Insurance!" |
 |
| |
|
| | |
| | | |
| | |
|
